Citigroup Cuts Oracle (NYSE:ORCL) Price Target to $375.00

Oracle (NYSE:ORCLFree Report) had its target price trimmed by Citigroup from $415.00 to $375.00 in a research report sent to investors on Thursday morning, Marketbeat Ratings reports. The brokerage currently has a buy rating on the enterprise software provider’s stock.

Several other brokerages also recently weighed in on ORCL. Rothschild & Co Redburn began coverage on Oracle in a report on Thursday, September 25th. They set a “sell” rating and a $175.00 price target for the company. Berenberg Bank raised their price objective on shares of Oracle from $202.00 to $306.00 and gave the company a “hold” rating in a research note on Monday, September 15th. Mizuho lifted their target price on shares of Oracle from $300.00 to $350.00 and gave the stock an “outperform” rating in a report on Wednesday, September 10th. Erste Group Bank cut shares of Oracle from a “buy” rating to a “hold” rating in a report on Monday, November 10th. Finally, Jefferies Financial Group raised their price target on shares of Oracle from $360.00 to $400.00 and gave the company a “buy” rating in a research report on Friday, October 17th. Four investment analysts have rated the stock with a Strong Buy rating, twenty-seven have given a Buy rating, eleven have given a Hold rating and two have issued a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $322.73.

Check Out Our Latest Report on ORCL

Oracle Trading Up 1.7%

Shares of NYSE ORCL opened at $218.04 on Thursday. Oracle has a 1 year low of $118.86 and a 1 year high of $345.72. The company has a debt-to-equity ratio of 3.33, a current ratio of 0.62 and a quick ratio of 0.62. The firm has a 50-day moving average of $253.08 and a 200 day moving average of $239.53. The stock has a market cap of $621.59 billion, a P/E ratio of 50.47, a price-to-earnings-growth ratio of 2.47 and a beta of 1.66.

Oracle (NYSE:ORCLGet Free Report) last announced its quarterly earnings data on Tuesday, September 9th. The enterprise software provider reported $1.47 earnings per share for the quarter, missing analysts’ consensus estimates of $1.48 by ($0.01). The business had revenue of $14.93 billion during the quarter, compared to analysts’ expectations of $15.04 billion. Oracle had a return on equity of 72.93% and a net margin of 21.08%.Oracle’s revenue for the quarter was up 12.2% compared to the same quarter last year. During the same quarter last year, the company posted $1.39 EPS. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. As a group, sell-side analysts expect that Oracle will post 5 EPS for the current fiscal year.

Oracle Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, October 23rd. Shareholders of record on Thursday, October 9th were issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend was Thursday, October 9th. Oracle’s dividend payout ratio is currently 46.30%.

Insider Buying and Selling

In other news, EVP Stuart Levey sold 19,758 shares of Oracle stock in a transaction dated Friday, October 10th. The stock was sold at an average price of $300.00, for a total transaction of $5,927,400.00. Following the transaction, the executive vice president directly owned 18,429 shares of the company’s stock, valued at $5,528,700. The trade was a 51.74% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Jeffrey Berg sold 49,365 shares of Oracle stock in a transaction that occurred on Tuesday, October 28th. The shares were sold at an average price of $283.02, for a total transaction of $13,971,282.30. Following the transaction, the director directly owned 151,999 shares in the company, valued at $43,018,756.98. This represents a 24.52% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 204,254 shares of company stock worth $60,227,807 in the last quarter. Company insiders own 40.90% of the company’s stock.

Hedge Funds Weigh In On Oracle

A number of hedge funds have recently made changes to their positions in the business. Strategic Investment Solutions Inc. IL raised its stake in Oracle by 1,753.0% during the 3rd quarter. Strategic Investment Solutions Inc. IL now owns 1,223 shares of the enterprise software provider’s stock valued at $344,000 after purchasing an additional 1,157 shares during the period. Allworth Financial LP raised its position in shares of Oracle by 1.1% during the third quarter. Allworth Financial LP now owns 320,789 shares of the enterprise software provider’s stock valued at $90,219,000 after buying an additional 3,465 shares during the last quarter. Swiss Life Asset Management Ltd lifted its holdings in shares of Oracle by 3.3% in the third quarter. Swiss Life Asset Management Ltd now owns 510,345 shares of the enterprise software provider’s stock worth $143,529,000 after buying an additional 16,167 shares in the last quarter. Innova Wealth Partners boosted its position in shares of Oracle by 3.8% during the third quarter. Innova Wealth Partners now owns 2,457 shares of the enterprise software provider’s stock worth $691,000 after acquiring an additional 90 shares during the last quarter. Finally, Stillwater Wealth Management Group purchased a new position in Oracle during the third quarter valued at $4,022,000. Institutional investors own 42.44% of the company’s stock.

Oracle Company Profile

(Get Free Report)

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.

Featured Articles

Analyst Recommendations for Oracle (NYSE:ORCL)

Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.